Technology | Mammography Reporting Software | June 12, 2019

Three Palm Software Releases WorkstationOne Version 1.8.8

Latest release of breast imaging workstation expands custom display mechanisms for new mammography CAD systems, decision support and breast density reports

Three Palm Software Releases WorkstationOne Version 1.8.8

June 12, 2019 — Three Palm Software announced the release of the 1.8.8 version of its breast imaging workstation, WorkstationOne. This release builds on the existing comprehensive support for mammography, with enhancements in several areas. An emphasis of this release is expanded custom display mechanisms for new mammography computer-aided detection (CAD) systems, decision support and breast density reports. This includes customized report display for approximately 20 different vendors (not all of which are available for clinical use yet).

Tomosynthesis CAD from vendors such as iCAD and ScreenPoint, and interactive decision support for ScreenPoint’s Transpara products, are all supported. The system can also automatically extract and display scoring information from the received reports and include that in the user’s reading worklist in order to prioritize reading order. Similarly, breast density information from vendors such as Volpara, Densitas and iCAD is extracted and displayed with the images, and can be used to set the initial state for reported breast density.

For more information: www.threepalmsoft.com

Related Content

GE Healthcare and Premier Inc. Developing One-stop Breast Clinic Model for U.S.
News | Mammography | October 21, 2019
GE Healthcare and Premier Inc. have announced a collaboration to develop a model to bring a same-day breast cancer...
Densitas Breast Density Assessment Software Joins Nuance AI Marketplace
News | Breast Density | October 21, 2019
Densitas Inc. announced that its U.S. Food and Drug Administration (FDA)-cleared densitas densityai breast density...
The Revolution Apex intelligent computed tomography (CT) scanner

The Revolution Apex intelligent computed tomography (CT) scanner. Image courtesy of GE Healthcare.

News | RSNA | October 18, 2019
At the 2019 annual meeting of the Radiological Society of North America (RSNA 2019), Dec. 1-6 in Chicago, GE Healthcare...
MaxQ AI's Intracranial Hemorrhage Software to be Integrated on Philips CT Systems
News | Artificial Intelligence | October 18, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that its Accipio intracranial hemorrhage (ICH...
A patient prepares to have a tomosynthesis-guided prone breast biopsy using the Hologic Affirm prone biopsy system.

A patient prepares to have a tomosynthesis-guided prone breast biopsy using the Hologic Affirm prone biopsy system.

Feature | Breast Biopsy Systems | October 17, 2019 | By Harriet Borofsky, M.D.
The current body of research supporting...
Feature | Breast Imaging | October 16, 2019 | By Jeff Zagoudis
On Jan. 1, 2017, the U.S.
Genia Sutton, intGenia Sutton, interim director of radiology

Genia Sutton, interim director of radiology, has seen the benefit to patients. “Five minutes is a lot of time if you are thinking you may have breast cancer,” she said. “Now, technologists aren’t as rushed. They can give a more personal touch because they can spend more time with their patients.”

Sponsored Content | Case Study | Mammography | October 10, 2019
When Cullman Regional Medical Center in Alabama decided to
RSNA Announces Intracranial Hemorrhage AI Challenge
News | Artificial Intelligence | October 08, 2019
The Radiological Society of North America (RSNA) recently launched its third annual artificial intelligence (AI)...
Hologic, Inc.’s Company’s Chairman, President and Chief Executive Officer Steve MacMillan, joined a number of employees to ring the Nasdaq Opening Bell for the 14th consecutive year on Oct. 2
News | Women's Health | October 04, 2019
Hologic, Inc.’s Company’s Chairman, President and Chief Executive Officer ...
Breast cancer awareness month is October
News | Clinical Case Studies | October 03, 2019
A decades-long decline in the breast cancer death rate continues, but has begun to slow in recent years, while breast